Exicure, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NASDAQ
XCUR
Exicure, INCExicure, Inc. is undergoing a significant strategic shift, divesting historical biotechnology assets to focus on new ventures including a blood cancer clinical trial and Korean entertainment and renewable energy businesses, while actively raising capital to address substantial doubt about its ability to continue as a going concern.